Skip to content
Tetanus toxoid adsorbed
N/A (tetanus toxoid adsorbed) is an unknown pharmaceutical. Tetanus toxoid adsorbed was first approved as N/a on 1999-12-09.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
N/a
Drug Products
FDA
EMA
Reference product - 351(a)
Reference product - 351(a)
Interchangeable product - 351(k)
Interchangeable product - 351(k)
Biosimilar product - 351(k)
Biosimilar product - 351(k)
Tetanus toxoid adsorbed
Tradename
Proper name
Company
Number
Date
Products
N/ATetanus Toxoid AdsorbedSanofi Pasteur Inc.A-103913 RX1999-12-09
1 products
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
195 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
TetanusD013742EFO_0005593A35782521361
DiphtheriaD004165EFO_0005549A36672320357
Whooping coughD014917EFO_0000650A37662017350
Meningococcal infectionsD008589EFO_0004249A3927151226
PoliomyelitisD011051EFO_0007450A8029718
MeningitisD008581EFO_0000584G03147113
Meningococcal meningitisD008585EFO_1001040A39.037111
Healthy volunteers/patients18211
Haemophilus influenzae type bD01974118110
Rheumatoid arthritisD001172EFO_0000685M06.911215
Show 11 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hepatitis bD0065092226
Relapsing-remitting multiple sclerosisD020529EFO_0003929314
Neisseria meningitidisD009345NCBITaxon_487134
DengueD003715A90224
Severe dengueD019595A91224
MeaslesD008457B051113
Pneumococcal pneumoniaD011018J13112
HepatitisD006505HP_0012115K75.9112
Falciparum malariaD016778EFO_0007444B5011
Only childD00986311
Show 5 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Hiv infectionsD015658EFO_0000764B202147
MelanomaD008545547
NeoplasmsD009369C803214
GlioblastomaD005909EFO_0000515213
Multiple myelomaD009101C90.0112
Colorectal neoplasmsD015179122
Ovarian neoplasmsD010051EFO_0003893C56112
B-cell chronic lymphocytic leukemiaD015451C91.1112
MedulloblastomaD008527112
Breast neoplasmsD001943EFO_0003869C50112
Show 14 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Brain neoplasmsD001932EFO_0003833C7133
GliomaD005910EFO_0000520112
Myelodysplastic syndromesD009190D46112
Myeloid leukemia acuteD015470C92.0112
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0112
Bcr-abl positive chronic myelogenous leukemiaD015464EFO_0000340112
Hodgkin diseaseD006689C81112
TrismusD01431311
Hepatitis cD006526B19.211
Extranodal nk-t-cell lymphomaD054391C86.011
Show 32 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
AstrocytomaD001254EFO_000027111
OligodendrogliomaD009837EFO_000063111
Neuromuscular monitoringD06188611
VasculitisD014657EFO_0006803M3111
SpondylarthritisD02524111
Muscle relaxationD00912611
Heterologous immunityD06478911
Rotavirus infectionsD01240011
Non-hodgkin lymphomaD008228C85.911
Delayed emergence from anesthesiaD05519111
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameTETANUS TOXOID ADSORBED
INN
Description
N/A (tetanus toxoid adsorbed) is an unknown pharmaceutical. Tetanus toxoid adsorbed was first approved as N/a on 1999-12-09.
Classification
Unknown
Drug class
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Identifiers
PDB
CAS-ID
RxCUI
ChEMBL IDCHEMBL2108876
ChEBI ID
PubChem CID
DrugBank
UNII ID
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 67 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
137 adverse events reported
View more details